Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease
Page 1 of 1
Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease
Jon Moulton Fri Mar 16, 2012 10:54 am
Friedrich T, Lambert AM, Masino MA, Downes GB. Mutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease. Dis Model Mech. 2012 Mar;5(2):248-58. Epub 2011 Nov 1.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» Knockdown of pnpla6 protein results in motor neuron defects in zebrafish
» Disruption of Eaat2b, a glutamate transporter, results in abnormal motor behaviors in developing zebrafish
» Distinct phenotypes in zebrafish models of human startle disease
» Robotic injection of zebrafish embryos for high-throughput screening in disease models
» Defining Hepatic Dysfunction Parameters in Two Models of Fatty Liver Disease in Zebrafish Larvae
» Disruption of Eaat2b, a glutamate transporter, results in abnormal motor behaviors in developing zebrafish
» Distinct phenotypes in zebrafish models of human startle disease
» Robotic injection of zebrafish embryos for high-throughput screening in disease models
» Defining Hepatic Dysfunction Parameters in Two Models of Fatty Liver Disease in Zebrafish Larvae
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum